Melbourne Clinical Trials

The Airway Study

The study drug is a potential new treatment for Cystic Fibrosis

13 nights
1 visits
  • Study Objective: To explore a potential new treatment for Cystic fibrosis (CF). It is hoped to be effective than the current treatments that are available and has fewer side effects.
  • Understanding Cystic Fibrosis: Cystic Fibrosis is a progressive, usually fatal genetic disease associated with severe health complications and a shortened lifespan.

  • Importance of Treatment: There is just over 3,600 people living with cystic fibrous in Australia, with no current cure and few effective treatments available.

Clinical Trial Details:

  • An independent ethics committee has approved this clinical trial.
  • Participants will be reimbursed for their time.

Call us on 1800 243 733 to discuss your eligibility today!

Eligibility

Biological Sex Healthy males or females
Age 18-55 years old (inclusive)
BMI 18 - 32 kg/m²
Weight At least 45kg+
Medication Not taking any medication (contraception permitted)
Medical History Nothing siginificant
Smoking History Non-smokers